Nevertheless, gathering evidence on the therapeutic implication of ACKR3/CXCR7 in atherosclerosis [103], myocardial infarction [27,28], pulmonary fibrosis [104], hepatic regeneration [105], its role in platelet pathophysiology and CAD [23,24,25,63] cannot be overlooked. This evidence concerns the gene ACKR3 and pulmonary fibrosis.